The Health Department is offering a grant to support a nationwide study on the risk of classic forms of Creutzfeldt-Jakob Disease (CJD) transmission through blood transfusions. This grant aims to continue the research initiated in 1995 to evaluate the potential transmission of CJD from donors diagnosed with the disease to recipients of blood products, providing critical insights for public health and blood safety measures. Applications are due by March 19, 2019.
Opportunity ID: 310644
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-CK-19-004 |
Funding Opportunity Title: | Study to Assess the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease (CJD) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 1 |
Assistance Listings: | 93.084 — Prevention of Disease, Disability, and Death by Infectious Diseases |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Nov 28, 2018 |
Last Updated Date: | Nov 28, 2018 |
Original Closing Date for Applications: | Mar 19, 2019 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
Current Closing Date for Applications: | Mar 19, 2019 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
Archive Date: | Apr 18, 2019 |
Estimated Total Program Funding: | $385,000 |
Award Ceiling: | $77,000 |
Award Floor: | $70,000 |
Eligibility
Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
Additional Information on Eligibility: | Single Source Competition: Eligibility Limited to the American Red Cross |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | The purpose of this Notice of Funding Opportunity is to enable the continuation of the active, nationwide study, begun in 1995, of recipients of blood products from donors who are subsequently diagnosed with classic forms of Creutzfeldt-Jakob Disease (CJD) in order to assess the risk of possible transmission of such forms of CJD by blood transfusion. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Deborah Loveys
hft6@cdc.gov Email:hft6@cdc.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 310644 Full Announcement-RFA-CK-19-004 -> RFA-CK-19-004 Final NOFO.pdf
Packages
Agency Contact Information: | Deborah Loveys hft6@cdc.gov Email: hft6@cdc.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.084 | RFA-CK-19-004 | Study to Assess the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease (CJD) | PKG00246531 | Nov 28, 2018 | Mar 19, 2019 | View |
Package 1
Mandatory forms
310644 RR_SF424_2_0-2.0.pdf
310644 PHS398_CoverPageSupplement_4_0-4.0.pdf
310644 RR_OtherProjectInfo_1_4-1.4.pdf
310644 PerformanceSite_2_0-2.0.pdf
310644 RR_KeyPersonExpanded_2_0-2.0.pdf
310644 RR_Budget_1_4-1.4.pdf
310644 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
310644 RR_SubawardBudget30_1_4-1.4.pdf